Furthermore, in NAFLD mouse models, platelets restrain HCC growth by enhancing CD8+ T cell-dependent anti-tumor immunity through P2Y12/leukotrienes-dependent CD40L release [111]. This evidence concerns the gene CD8A and hepatocellular carcinoma.